CLINICAL_TRIALS
research
· 2009-12-03
Clinical Trial Update: Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease [NA]
Summary
This document provides an update on a clinical trial evaluating transapical implantation of the Ventor Embracer valve for severe aortic valve disease, with the …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ventor Technologies | Conditions: Aortic Valve Disease | NA | Status: UNKNOWN